Peter Kalivas to Naloxone
This is a "connection" page, showing publications Peter Kalivas has written about Naloxone.
Connection Strength
0.244
-
Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 1992 Jul; 12(7):2623-32.
Score: 0.097
-
N-acetylcysteine mitigates acute opioid withdrawal behaviors and CNS oxidative stress in neonatal rats. Pediatr Res. 2020 07; 88(1):77-84.
Score: 0.041
-
Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens. Psychopharmacology (Berl). 1992; 108(1-2):141-6.
Score: 0.023
-
Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum. J Pharmacol Exp Ther. 1990 Mar; 252(3):1370-7.
Score: 0.021
-
Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 1987 Sep; 242(3):757-63.
Score: 0.017
-
Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J Pharmacol Exp Ther. 1987 Apr; 241(1):328-37.
Score: 0.017
-
Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization. J Pharmacol Exp Ther. 1985 Nov; 235(2):537-43.
Score: 0.015
-
Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther. 1983 Oct; 227(1):229-37.
Score: 0.013